Skip to search.
 BSE Up 0.19% NSE Up 0.28%
Streaming
Ticker Tape: On

More On RAYLA.BO

Quotes

Charts

News & Info

  • Headlines
  • Company Events

Company

Analyst Coverage

  • Analyst Opinion
  • Analyst Estimates

Ownership

  • Major Holders
  • Insider Transactions
  • Insider Roster

Financials

  • Income Statement
  • Balance Sheet
  • Cash Flow

Raymed Laboratories Ltd (RAYLA.BO)

-BSE

11.34 Down 0.59(4.95%) 17 May 3:16PM

Add to Portfolio
Prev Close:11.93
Open:12.52
Bid:11.34
Ask:11.34
1y Target Est:N/A
Beta:N/A
Next Earnings Date:N/A
Day's Range:11.34 - 12.52
52wk Range:7.98 - 30.65
Volume:340
Avg Vol (3m):2,979
Market Cap:41.57M
P/E (ttm):N/A
EPS (ttm):N/A
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in INR.

Headlines

  • No Headlines available for RAYLA.BO at this time.

Comparison

Symbol% ChgMkt Cap
RAYLA.BODown 4.95%41.57M
TMOUp 0.90%30.96B
WYETH.NSDown 0.80%18.51B
WYETH.BOUp 0.35%18.63B
AUp 1.27%15.72B
» More Competitors

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):47.45
Ex-Dividend Date:N/A
» More Key Statistics

Analysts

Annual EPS Est () :N/A
Quarterly EPS Est () :N/A
Mean Recommendation*:N/A
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Raymed Labs Limited engages in manufacturing and trading pharmaceutical medicines for humans and animals in India. Its products include injectables, vitamin premixes, and calcium based herbal feed additives. View More
Company Profile | Industry
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback